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Abstract 
Single walled carbon nanotubes as free-radical scavengers and novel drug carriers are important in the drug delivery systems 
because of their high selectivity to target for cancer cells. Quercetin, one of Flavonoids derivatives, has effective chemopreventive 
and anticancer properties. This study was done to investigate the effect of configuration between SWCNT (5,5) and Quercetin at 
gas phase and polarizable continuum model (PCM). Calculations have been done at the DFT level with using of hybrid density 
functional (B3LYP) and 6-31G (d,p) basis set. Results showed that the gas phase or PCM had no significant effect on CNT beside 
Quercetin as drug delivery systems.  
© 2015 The Authors. Published by Elsevier Ltd. 
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1. Introduction 
A group of polyphenolic compounds widely found in the medicinal plants, vegetables, fruit juices and a variety of 
beverages are flavonoids, Moo-Huchin et al. (2015),  Sieliwoniuk et al. (2015). Flavonoids, mainly quercetin 
derivatives, are considered as dietary constituents and they have a significant role in human health, including 
cardiovascular protection, anticancer activity, antiulcer effects, antiallergic, antiviral, and anti-inflammatory 
properties, Hussain et al. (2015). Quercetin, whose anticancer properties have been verified in vivo and in vitro 
experiments, is one of the natural antioxidants, Russo et al. (2014). Studies indicated that quercetin has beneficial 
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effects on inhibition of breast, colon, prostate, ovary, endometrium, and lung tumor cancer cells. Also quercetin is 
used as ions chelating agent and it prevents reactions between DNA and ions, Jakhar et al. (2014),  Li et al. (2014). 
Quercetin is widely distributed in main food resources such as fruits and vegetables especially citrus, apple, onion, 
parsley, green tea, olive oil, grape, cherry, black mulberry, dogberry, and raspberry, Bukhari et al. (2008). Scientists 
have investigated new controlled drug delivery systems in order to get different achievement, including: delivery of 
therapeutic agents to the desired site, enhancing bioavailability and drug protection, Doane and Burda (2012), Kumara 
and Mohammad (2011), Peppas and Blanchette (2004). These investigations caused nanomedicine a new emerging 
field includes the application of nanotechnology in medicine. It has potential to develop area of therapeutic delivery 
Amiji (2006),  Kayser et al. (2005). A group of new nanoscale materials including: nanoparticles, nanotubes, 
nanofibers, dendrimers, liposomes, polymer micelles, nanogels, nanocrystals, viral vectors, and virus-like particles 
have been studied for drug delivery applications in recent years Amiji (2006),  Hughes (2005),  Regi et al. (2007),  
Wei et al. (2007). In these materials, CNTs that has unique chemical and physical properties has been considered more 
in drug delivery applications Meng et al. (2012), Biju  (2014). CNTs can be used in cancer therapy and other areas of 
medicine as a drug-delivery vehicles or nanocarriers without damaging the healthy tissues, Kesharwani et al. (2014), 
Prakash et al. (2011). The polymeric part (polymethacrylic acid, PMAA) increases the flavonoid water solubility and 
enhances its stability in order to have a sustained activity over time, Cirillo et al. (2013), López-De-Dicastillo et al. 
(2012), Leonarduzzi et al. (2010). Today these nanotubes are used to deliver cancerous and non-cancerous drugs to 
different cells in vitro and in vivo and it is hoped that they would be used in gene therapy, vaccination, and different 
cancer treatments in the future, Mura et al. (2013), Fabbro et al. (2012). Because theoretical study of the interaction 
between SWCNTs and Quercetin has not been done yet our main objective in the present study is to investigate 
theoretically the interaction of SWCNTs beside Quercetin with four types of different configuration including covalent 
and noncovalent bindings. We hope the results presented could lead to better condition for the usage of nanostructures 
in assisting Quercetin as drug carriers. 
2. Computational details        
All the calculations have been done at the DFT level with using of hybrid density functional (B3LYP) and 6-31G 
(d,p) basis set at gas phase and polarizable continuum model (PCM). The zero point energies (∆ZPE), electronic 
energies (∆E), enthalpies (∆H) and free Gibbs energies (∆G) were calculated using the following equation, Veloso et 
al. (2006):  
∆E (state x) = E state X - E CNTCOOH- E Q 
where E state X is the total energy of the nanotube and MAA with the attached Quercetin, ECNTCOOH is the electronic 
energy of the CNT and MAA (CNTCOOH), and EQ is the electronic energy of the Quercetin. All calculations were 
performed using the GAUSSIAN 03 program, Frisch et al. (2004).  
3. Results and Discussion  
Figure 1 shows the graphical representations of the optimized geometries carbon nanotube (5,5), carbon 
nanotube/MAA and carbon nanotube/MAA beside Quercetin at four differences configurations including covalent 
and noncovalent bindings. Table 1 and 2 display the values of the zero-point energies (ZPE), electronic energies, 
enthalpies and Gibbs free energy for CNT, CNTCOOH and CNTCOOH/Q at different states using B3LYP with 6-
31G (d,p) basis sets at gas phase and polarizable continuum model (PCM), respectively. Table 3 and 4 display the 
calculated relative energies (∆E), enthalpies (∆H) and free Gibbs energies (∆G) in gas phase and PCM, for CNT beside 
Quercetin at the room temperature. From Table 3 and 4, it can be seen that state 3 has less values of relative energies 
(∆E), enthalpies (∆H) and free Gibbs energies (∆G) than three other states in gas phase and PCM.  
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     Table 1. Theoretical data at gas phase. 
 ZPE(kJ/mol) Energies(kJ/mol) Enthalpies(kJ/mol) Gibbs Free 
Energy(kJ/mol) 
CNTCOOH gas -3806.186782 -3806.135284 -3806.134340 -3806.259373 
Quercetic gas 
State 1 
State 2 
State 3 
-1104.260823 
-4908. 615314 
-4909.054267 
-4910.165615 
-1104.242157 
-4908.194513 
-4908.95782 
-4910.094093 
-1104.241213 
-4908.233194 
-4908.875214 
-4910.093149 
-1104.307578 
-4908.269507 
-4908.965024 
-4910.268031 
State 4 -4909.151456 -4909.15704 -4909.162347 -4909.162354 
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Fig. 1. Optimized geometrical parameters of (a) CNT (5,5), b) MAA;  (c) CNT/MAA;  (d) State 1;  (e) State 2;  (f) State 3;  (g) State 4 at gas 
phase and PCM. 
 
 
 
 
Table 2. Theoretical data at polarizable continuum model (PCM). 
 ZPE(kJ/mol) Energies(kJ/mol) Enthalpies(kJ/mol) Gibbs Free 
Energy(kJ/mol) 
CNTCOOH gas -3806.204288 -3806.152475 -3806.151531 -3806.277063 
Quercetic gas 
State 1 
State 2 
State 3 
-1103.980293 
-4909.196135 
-4908.947821 
-4909.541961            
-1103.962846 
-4909.124150 
-4908. 646985 
-4909.742876 
-1103.961901 
-4909.123206 
-4908.939071 
-4909.986597 
-1104.024678 
-4909.296208 
-4908.067654 
-4909.024978 
State 4 -4908.767924 -4908.698645 -4908.697701 -4808.863920 
 
 
Table 3. Calculated relative electronic energies (kJ/mol), enthalpies (kJ/mol) and free Gibbs energies (kJ/mol) in gas phase. 
 ZPE(kJ/mol) Energies(kJ/mol) Enthalpies(kJ/mol) Gibbs Free 
Energy(kJ/mol) 
State 1 4721.31 5725.71 5613.11 6032.78 
State 2 
State 3 
State 4 
2189.34 
745.93 
3406.01 
3730.30 
749.92 
3207.76 
 3935.31 
739.28 
3180.73 
3698.30 
280.54 
3180.71 
 
 
 
 
 
 
 
135 S. Daneshmehr /  Procedia Materials Science  11 ( 2015 )  131 – 136 
Table 4. Calculated relative electronic energies (kJ/mol), enthalpies (kJ/mol) and free Gibbs energies (kJ/mol) in PCM. 
 ZPE(kJ/mol) Energies(kJ/mol) Enthalpies(kJ/mol) Gibbs Free 
Energy(kJ/mol) 
State 1 2592.432 2598.95 2598.803 2635.519 
State 2 
State 3 
State 4 
3243.747 
1685.348 
3715.608 
3868.851 
976.0626 
3715.028 
 3081.78 
334.1717 
3714.881 
5857.955 
3346.942 
266064.4 
 
4. Conclusion 
Comparison studies of DFT calculations at B3LYP with 6-31G (d,p) basis set at gas phase and PCM for CNT and 
MAA beside Quercetin in order to find the best configuration at drug delivery system were done. Results indicated 
that different configurations had no significant effects at gas phase and PCM and state 3 was the best nanocarrier 
among other states. 
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